Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis

G Trencsényi, Z Képes - International Journal of Molecular Sciences, 2023 - mdpi.com
Angiogenesis-related cell-surface molecules, including integrins, aminopeptidase N,
vascular endothelial growth factor, and gastrin-releasing peptide receptor (GRPR), play a …

Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1, 4, 7, 10 …

I Ioannidis, G Lefkaritis, SN Georgiades… - International Journal of …, 2024 - mdpi.com
Scandium (Sc) isotopes have recently attracted significant attention in the search for new
radionuclides with potential uses in personalized medicine, especially in the treatment of …

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA

I Kálmán-Szabó, JP Szabó, V Arató, N Dénes… - International Journal of …, 2022 - mdpi.com
Gastrin-releasing peptide receptors (GRPR) are overexpressed in prostate cancer (PCa).
Since bombesin analogue aminobenzoic-acid (AMBA) binds to GRPR with high affinity …

State of the art and future perspectives of new radionuclides in Nuclear Medicine

JJ Rosales, ML Domínguez, L Sancho, E Prieto… - Revista Española de …, 2025 - Elsevier
This continuing education analyzes recent advances in Nuclear Medicine focused on the
development of new radiopharmaceuticals that improve both the diagnosis and treatment of …

Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I

JJ Rosales, ML Domínguez, L Sancho, E Prieto… - Revista Española de …, 2025 - Elsevier
En esta formación continuada se analizan los recientes avances en Medicina Nuclear
centrados en el desarrollo de nuevos radiofármacos que mejoran tanto el diagnóstico como …